Highlights Novo Nordisk AS CINNOBER BOAT

Equities

0QIU

DK0060534915

Delayed CINNOBER BOAT Other stock markets			5-day change	1st Jan Change
- ^DKK	-.--%		-.--%	-.--%

07-02	Tesla, megacaps drive S&P 500, Nasdaq higher; rates outlook in focus	RE
07-02	Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tesla, megacaps drive S&P 500, Nasdaq higher; rates outlook in focus	07-02	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	07-02	MT
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount	07-02	MT
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	07-02	MT
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro	07-01	RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says	06-28	RE
European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk	06-27	MT
Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot	06-27	MT
Novo Nordisk to Limit Launch of Wegovy in China, Executive Says	06-27	MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	06-26	MT
2seventy Bio Sells Gene Editing Therapy To Novo Nordisk for Up To $40 Million	06-26	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	06-26	MT
Sector Update: Health Care Stocks Lower in Afternoon Trading	06-26	MT
Sector Update: Health Care	06-26	MT
European Equities Close Lower in Wednesday Trading	06-26	MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	06-26	MT
Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial	06-26	MT
Novo Nordisk Halts Late-stage Hypertension, Kidney Disease Treatment Trial; DKK6 Billion Impairment Loss Expected	06-26	MT
Novo Nordisk: trial failure and impact on results	06-26	CF
Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial	06-26	MT